IND, Clinical Trail for small-molecule and biologics, NDA, Marketing Submission for small-molecule drugs, Class 1 MD, Mostly Exempt or 510 (k), Class 2 MD, 510 (k) for substantially equivalent MD, Class 3 MD, PreMarkter Approval, Class 1 & 2 Noval MD, De Novo, HDE, For rare disease or condition affecting fewer than 8000 individual per year in US, Office of combination products, Confirm which is the lead and the respective pathway

Test

由
列印
嵌入

視覺風格

顯示所有
活動設定 排行榜 作業

活動設定

排行榜

更像這樣

GN - NI
GN - NI
由
問答遊戲
GN - NI
GN - NI
由
測驗
Drug Categories
Drug Categories
由
按組排序
GN/NI
GN/NI
由
測驗
NMT 1 (advertisement)
NMT 1 (advertisement)
由
測驗
NMT 4 (advertisement)
NMT 4 (advertisement)
由
測驗
NMT 10 (advertisement)
NMT 10 (advertisement)
由
測驗
NMT 11 (advertisement)
NMT 11 (advertisement)
由
測驗

切換範本

恢復自動保存: ?